Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials

Wenying Zhang,Yang Liu,Yao Wang,Chunmeng Wang,Qingming Yang,Zhu Hl,Weidong Han

Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials

2017

Wenying Zhang
Yang Liu
Yao Wang
Chunmeng Wang
Qingming Yang
Zhu Hl
Weidong Han

Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials

Keywords:

Immunology
Oncology
Biology
Lymphoma
Diabetes mellitus
Refractory
B-Cell Non-Hodgkin Lymphoma
Internal medicine
Cart
follow up results
long term safety
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations